Clin2
NCT07226232Possibly a fitRecruiting

Psilocybin for veterans with treatment-resistant depression

Major Depression

Treatments studied

Part of Mental health clinical trials.

This study tests whether psilocybin (a psychedelic substance) can help veterans with depression that hasn't improved with standard treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
240 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are a U.S. military veteran.
  • You have been diagnosed with major depressive disorder and have not responded to at least two different antidepressant treatments.
  • You are currently experiencing a major depressive episode (a period of intense sadness and loss of interest).
  • You do not have a history of bipolar disorder, schizophrenia, or other psychotic disorders, and no immediate family member with these conditions.
  • You have not used any psychedelic drugs (like LSD, psilocybin, MDMA, etc.) in the past 6 months.
  • You do not have a severe head injury, certain heart problems, or other serious medical conditions that would make the study unsafe for you.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07499583Not yet recruiting· Phase 1/Phase 2
Psilocybin therapy for depression and substance use in veterans and first responders

This trial tests whether psilocybin-assisted psychotherapy can help veterans and first responders with treatment-resistant depression and a co-occurring substance use disorder. It aims to see if this approach reduces depression and substance use.

Indianapolis, Indiana
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas
NCT07792538Not yet recruiting· Phase 2
Psilocybin therapy for veterans with PTSD

This study tests whether psilocybin (a psychedelic substance) combined with psychotherapy can help veterans with PTSD who haven't improved with standard treatments. The treatment involves a few sessions where you take psilocybin under supervision.

Oegstgeest
NCT06378229Recruiting· Phase 2
Psilocybin for hospitalized treatment-resistant depression

This trial tests whether a single dose of psilocybin can help hospitalized patients with tough-to-treat depression. It focuses on people who haven't improved with standard antidepressants and need a new option.

Ghent, Oost-Vlaanderen
NCT06989957Recruiting· Phase 1
Psilocybin and MDMA therapy for PTSD in veterans

This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.

Baltimore, Maryland
NCT06512194Recruiting· Phase 2
Psilocybin for depression study

This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.

Edwards, Colorado

Hear when a new Major Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.